Hyaluronic acid nanoemulsions improve piplartine cytotoxicity in 2D and 3D breast cancer models and reduce tumor development after intraductal administration (2022)
- Authors:
- USP affiliated authors: STEINER, ALEXANDRE ALARCON - ICB ; LOTUFO, LETICIA VERAS COSTA - ICB ; LOPES, LUCIANA BIAGINI - ICB ; SALATA, GIOVANNA CASSONE - ICB ; PASSOS, JULIA SAPIENZA - ICB ; BRANCO, PAOLA CRISTINA - ICB ; DARTORA, VANESSA FRANCO CARVALHO - ICB
- Unidade: ICB
- DOI: 10.1016/j.ijbiomac.2022.07.162
- Subjects: IMUNOLOGIA; FARMACOLOGIA; NEOPLASIAS MAMÁRIAS; ALCALOIDES; PRODUTOS NATURAIS; ÓLEOS ESSENCIAIS; CÉLULAS CULTIVADAS DE TUMOR; BIOPOLÍMEROS; CITOTOXINAS; NANOPARTÍCULAS; QUITOSANA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: International Journal of Biological Macromolecules
- ISSN: 1879-0003
- Volume/Número/Paginação/Ano: v. 219, p. 84-95, 2022
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
- Licença: publisher-specific-oa
-
ABNT
DARTORA, Vanessa Franco Carvalho et al. Hyaluronic acid nanoemulsions improve piplartine cytotoxicity in 2D and 3D breast cancer models and reduce tumor development after intraductal administration. International Journal of Biological Macromolecules, v. 219, p. 84-95, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.ijbiomac.2022.07.162. Acesso em: 27 dez. 2025. -
APA
Dartora, V. F. C., Salata, G. C., Passos, J. S., Branco, P. C., Silveira, E., Steiner, A. A., et al. (2022). Hyaluronic acid nanoemulsions improve piplartine cytotoxicity in 2D and 3D breast cancer models and reduce tumor development after intraductal administration. International Journal of Biological Macromolecules, 219, 84-95. doi:10.1016/j.ijbiomac.2022.07.162 -
NLM
Dartora VFC, Salata GC, Passos JS, Branco PC, Silveira E, Steiner AA, Costa-Lotufo LV, Lopes LB. Hyaluronic acid nanoemulsions improve piplartine cytotoxicity in 2D and 3D breast cancer models and reduce tumor development after intraductal administration [Internet]. International Journal of Biological Macromolecules. 2022 ; 219 84-95.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1016/j.ijbiomac.2022.07.162 -
Vancouver
Dartora VFC, Salata GC, Passos JS, Branco PC, Silveira E, Steiner AA, Costa-Lotufo LV, Lopes LB. Hyaluronic acid nanoemulsions improve piplartine cytotoxicity in 2D and 3D breast cancer models and reduce tumor development after intraductal administration [Internet]. International Journal of Biological Macromolecules. 2022 ; 219 84-95.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1016/j.ijbiomac.2022.07.162 - Contributions of nanotechnology to the intraductal drug delivery for local treatment and prevention of breast cancer
- Thermosensitive polymeric nanoparticles for drug Co-encapsulation and breast cancer treatment
- Optimization of composition and obtainment parameters of biocompatible nanoemulsions intended for intraductal administration of piplartine (piperlongumine) and mammary tissue targeting
- Phosphatidylcholine-based nanoemulsions for paclitaxel and a P-Glycoprotein inhibitor delivery and breast cancer intraductal treatment
- Development of a method for quantitative determination of the cytotoxic agent piplartine (piperlongumine) in multiple skin layers
- A lipid-based in situ-forming hexagonal phase for prolonged retention and drug release in the breast tissue
- Rethinking breast cancer chemoprevention: technological advantages and enhanced performance of a Nanoethosomal-Based Hydrogel for topical administration of Fenretinide
- Monoolein-based nanodispersions for cutaneous co-delivery of methylene blue and metformin: thermal and structural characterization and effects on the cutaneous barrier, skin penetration and cytotoxicity
- Optimization of nanoemulsified systems containing lamellar phases for co-delivery of celecoxib and endoxifen to the skin aiming for breast cancer chemoprevention and treatment
- Development, skin targeting and antifungal efficacy of topical lipid nanoparticles containing itraconazole
Informações sobre o DOI: 10.1016/j.ijbiomac.2022.07.162 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
